陕西首富联合瑞典巨头，低调出海

Core Viewpoint - The article discusses the strategic partnership between Juzi Bio and Nordberg Medical, focusing on the global development and commercialization of recombinant collagen in the medical aesthetics and biomedical fields, amidst challenges in the domestic consumption market [1][2]. Financial Performance - In the first half of 2025, Juzi Bio achieved revenue of 3.113 billion yuan, a year-on-year increase of 22.5%, with net profit exceeding 1.182 billion yuan, also showing over 20% growth [4]. - Despite overall growth, key financial indicators reveal challenges, such as a 27.5% increase in sales costs to 570 million yuan, which outpaced revenue growth, leading to pressure on gross margins [5]. - Research and development expenses decreased by 15.5% to 41.2 million yuan, attributed to some projects entering the results transformation phase [5]. Market Challenges - The main brand "Kefumei" reported revenue of 2.54 billion yuan, growing 22.7%, but faces challenges from industry slowdowns and intensified competition [5]. - Reports indicate a double-digit decline in sales during the Double Eleven shopping festival, with significant reductions in GMV on platforms like Douyin [5]. Strategic Shift - Juzi Bio is transitioning from a focus on scale expansion to a strategy emphasizing profit stability and structural adjustment due to market pressures [5]. - The recent approval of a Class III medical device registration certificate for recombinant collagen products marks a significant shift from consumer skincare to professional medical applications, enhancing the company's market position [7]. International Collaboration - The partnership with Nordberg Medical allows Juzi Bio to leverage established global networks, facilitating entry into the projected $10 billion market for injection-based medical aesthetics by 2026 [2]. - This collaboration represents a strategic "borrowing a boat to go to sea" approach, enabling Juzi Bio to access existing commercial channels without starting from scratch [8]. Product Development and Market Strategy - Juzi Bio's focus on professional medical products is expected to reshape its marketing strategies, moving from consumer-driven sales to professional education and B2B promotion [9]. - The company aims to build a dual engine of "consumer brand" and "professional technology" by reallocating resources towards products with global registration potential and strengthening international business teams [9].